George L. Drusano
Affiliations: | Albany Medical College of Union University |
Area:
Biomedical Engineering, Pharmacology, Molecular Biology, Microbiology BiologyGoogle:
"George Drusano"Children
Sign in to add trainee| Nelson L. Jumbe | grad student | 2001 | Albany Medical College of Union University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jiao Y, Yan J, Sutaria DS, et al. (2024) Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial Agents and Chemotherapy. e0139423 |
| Jacobsson S, Golparian D, Oxelbark J, et al. (2023) Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against in a gonococcal hollow-fiber infection model. Frontiers in Pharmacology. 14: 1291885 |
| Tilanus A, Drusano G. (2023) Inoculum-Based Dosing: A Novel Concept for Combining Time with Concentration-Dependent Antibiotics to Optimize Clinical and Microbiological Outcomes in Severe Gram Negative Sepsis. Antibiotics (Basel, Switzerland). 12 |
| Tilanus A, Drusano G. (2023) Optimizing the Use of Beta-Lactam Antibiotics in Clinical Practice: A Test of Time. Open Forum Infectious Diseases. 10: ofad305 |
| Jacobsson S, Golparian D, Oxelbark J, et al. (2022) Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating infections. Frontiers in Pharmacology. 13: 1035841 |
| Jacobsson S, Golparian D, Oxelbark J, et al. (2022) Pharmacodynamic Evaluation of Zoliflodacin Treatment of Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology. 13: 874176 |
| Durand-Reville TF, Miller AA, O'Donnell JP, et al. (2021) Rational design of a new antibiotic class for drug-resistant infections. Nature |
| Jacobsson S, Golparian D, Oxelbark J, et al. (2021) Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against in a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology. 12: 682135 |
| Drusano GL, Bonomo RA, Marshall SM, et al. (2021) Emergence of resistance to ceftazidime-avibactam in a derepressed producing isolate in a Hollow Fiber Infection Model. Antimicrobial Agents and Chemotherapy |
| Lodise TP, Drusano G. (2021) Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |